Why do they induce labor in a pregnant woman at 37 weeks of gestation with polyhydramnios (excessive amniotic fluid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Induction is Performed at 37 Weeks with Polyhydramnios

Induction at 37 weeks for polyhydramnios is performed to prevent serious maternal and fetal complications, including stillbirth, cord prolapse, placental abruption, abnormal fetal presentation, and postpartum hemorrhage—risks that outweigh the benefits of continuing pregnancy once term gestation is reached. 1, 2, 3

Understanding the Risks of Polyhydramnios

Polyhydramnios carries substantial perinatal mortality risk that justifies earlier delivery:

  • Stillbirth risk is independently elevated with odds ratios ranging from 1.8 to 5.8, even in isolated cases without fetal anomalies 1
  • In a cohort exceeding 200,000 singleton births, polyhydramnios independently increased stillbirth risk (OR 1.8; 95% CI 1.4-2.2) 1
  • Preterm delivery occurs in up to 66% of polyhydramnios cases, with preterm labor before 37 weeks in 48.8% of severe cases 1

Specific Complications That Drive Early Delivery

The excessive amniotic fluid volume creates mechanical and physiologic problems:

  • Cord prolapse risk increases dramatically due to the fluid cushion allowing the umbilical cord to slip past the presenting part 2, 3
  • Abnormal fetal presentations (breech, transverse, face, brow) occur more frequently, with non-vertex presentations seen in 7.8% versus 1% in controls 4
  • Premature rupture of membranes (PPROM) is more common, potentially leading to sudden decompression and placental abruption 2, 3
  • Postpartum hemorrhage occurs due to uterine overdistension causing atony after delivery 2, 3

Why 37 Weeks Specifically

The timing balances fetal maturity against escalating risks:

  • 37 weeks represents early term gestation where neonatal respiratory morbidity is minimal compared to earlier gestational ages 5
  • The FDA label for oxytocin specifically indicates induction "at or near term, when delivery is in the best interest of mother and fetus" for conditions including maternal complications 6
  • Continuing pregnancy beyond 37 weeks with polyhydramnios increases cumulative exposure to stillbirth risk without meaningful fetal benefit 1

The Delivery Management Approach

When polyhydramnios reaches 37 weeks, the management strategy focuses on controlled delivery:

  • Cesarean section rates are already elevated in polyhydramnios (45.4% versus 8% in controls), even after excluding induced labor and abnormal presentations 4
  • Controlled amniotomy during induction allows gradual fluid release, reducing the risk of cord prolapse and placental abruption compared to spontaneous rupture 4
  • Delivery at a tertiary center is recommended for severe polyhydramnios due to the significant possibility of undetected fetal anomalies and need for immediate neonatal resuscitation 3

Critical Distinction: Mild vs Severe Polyhydramnios

The approach differs based on severity:

  • Mild idiopathic polyhydramnios (without identified cause or fetal anomalies) may be managed expectantly with spontaneous labor at term, with induction not recommended before 39 weeks absent other indications 3
  • Severe polyhydramnios or cases with identified pathology warrant earlier intervention at 37 weeks due to the compounding risks 1, 3

Common Pitfall to Avoid

Do not delay delivery waiting for spontaneous labor when severe polyhydramnios is present at 37 weeks—the cumulative stillbirth risk increases with each additional week, and the mechanical complications (cord prolapse, abruption) can occur suddenly and catastrophically 1, 2. The Society for Maternal-Fetal Medicine explicitly recommends against routine expectant management in these cases 3.

References

Guideline

Polyhydramnios in the Third Trimester

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Polyhydramnios: Causes, Diagnosis and Therapy.

Geburtshilfe und Frauenheilkunde, 2013

Research

SMFM Consult Series #46: Evaluation and management of polyhydramnios.

American journal of obstetrics and gynecology, 2018

Research

Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios.

Journal of gynecology obstetrics and human reproduction, 2017

Guideline

Induction of Labour Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the significance of unstable lie in patients with polyhydramnios (excess amniotic fluid)?
What causes hydramnios?
What are the causes of polyhydramnios?
What are the causes of polyhydramnios (excessive amniotic fluid) in pregnant women, particularly those with a history of diabetes (diabetes mellitus) or carrying multiple fetuses (e.g. twins or triplets)?
Do I need to send my pregnant patient with polyhydramnios for a Maternal-Fetal Medicine (MFM) referral?
What is the next step in management for a patient with septic arthritis of the knee who is already on antibiotics?
Can a patient with depression and insomnia switch from desvenlafaxine (serotonin-norepinephrine reuptake inhibitor) to doxepin (tricyclic antidepressant) for management?
What CT scan should be ordered for an elderly female patient with severe back pain between the shoulder blades and vomiting?
What diagnostic techniques and treatment options are recommended for a patient with diarrhea, suspected cytomegalovirus (CMV) infection, and immunosuppression due to immunosuppressors (e.g. immunosuppressive therapy) use?
What type of respiratory failure can occur in an adult patient with a complex medical history, including a recent soft tissue infection and possible traumatic injury or cervical spine condition, due to cervical spine compression?
What is the best treatment option for a patient with Ehlers-Danlos (Ehlers-Danlos Syndrome) hypermobile type, experiencing long-term uncontrolled depression, anxiety, and insomnia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.